Kategori: Publikationer

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.

van Vollenhoven RF, Geborek P, Forslind K, Albertsson K, Ernestam S, Petersson IF, Chatzidionysiou K, Bratt J; Swefot study group. Lancet. 2012 May 5;379(9827):1712-20.

Education and benchmarking among physicians may facilitate sick-listing practice.

Bremander AB, Hubertsson J, Petersson IF, Grahn B.
J Occup Rehabil. 2012 Mar;22(1):78-87. doi: 10.1007/s10926-011-9321-5.PMID: 21769594

In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.

Rezaei H, Saevarsdottir S, Forslind K, Albertsson K, Wallin H, Bratt J, Ernestam S, Geborek P, Pettersson IF, van Vollenhoven RF. Ann Rheum Dis. 2012 Feb;71(2):186-91.

Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment.
Happonen KE, Saxne T, Geborek P, Andersson M, Bengtsson AA, Hesselstrand R, Heinegård D, Blom AM.
Arthritis Res Ther. 2012 Jan 20;14(1):R15. doi: 10.1186/ar3694.

Cookie-samtycke med Real Cookie Banner